{"id":"26110082932","number":"26110082932","name":"Kevin Mottus, Outreach Director at CA Brain Tumor Assn.","source_name":"Kevin Mottus\nOutreach Director at CA Brain Tumor Assn.","organization":"","posted":"2026-10-21","received":"2026-10-21","body":"","attachments":["https://www.fcc.gov/ecfs/document/26110082932/1","https://www.fcc.gov/ecfs/document/26110082932/2","https://www.fcc.gov/ecfs/document/26110082932/3","https://www.fcc.gov/ecfs/document/26110082932/4","https://www.fcc.gov/ecfs/document/26110082932/5","https://www.fcc.gov/ecfs/document/26110082932/6"],"attachment_names":{"https://www.fcc.gov/ecfs/document/26110082932/1":"FCC Comment-Kevin Mottus-CA Brain Tumor Assn-REV19.pdf","https://www.fcc.gov/ecfs/document/26110082932/2":"Changes in the excitability of primary hippocampal neurons following exposure to 3.0GHz radiofrequency electromagnetic fields.pdf","https://www.fcc.gov/ecfs/document/26110082932/3":"Case Report- Both Parents and their Three Children Developed Symptoms of the Microwave Syndrome while on Holiday near a 5G Tower.pdf","https://www.fcc.gov/ecfs/document/26110082932/4":"Case Report- The Microwave Syndrome after Installation of 5G Emphasizes the Need for Protection from Radiofrequency Radiation.pdf","https://www.fcc.gov/ecfs/document/26110082932/5":"Cellular Phone Use and Risk of Tumors- Systematic Review and Meta-Analysis.pdf","https://www.fcc.gov/ecfs/document/26110082932/6":"CeO2NPs relieve radiofrequency radiation, improve testosterone synthesis, and clock gene expression in Leydig cells by enhancing antioxidation.pdf"},"attachment_inventory":true,"withheld":false,"source":"https://www.fcc.gov/ecfs/filing/26110082932","filing_type":"COMMENT","proceedings":"WTB 25-276\nET 13-84\nWC 21-93\nGN 25-59\nOET 19-226\nGN 20-32\nGN 25-133\nIB 18-86\nWC 26-133\nGN 26-74\nWC 13-184\nWC 21-455\nWTB 25-217\nSB 25-180\nSB 26-54\nGN 22-352\nWTB 23-158\nGN 14-177\nOET 26-245\nPSHSB 26-197","capture_reviewed":false,"captured_at":"2026-10-22T18:50:57.783Z","supplied_classification":null,"tags":["attachments-only"],"source_hash":"b31a74e5bdd146e267c42b60da257ee1b576482a66a2c8b18af4bdc6865802a4","slug":"attachments-only-filing-26110082932","classification":{"id":"26110082932","body_sha256":"e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855","status":"text_matched","primary_topic":"attachments-only","topics":[{"id":"attachments-only","evidence":""}],"summary":"","method":"Local topic rules v1; exact supporting passages; not an AI or medical review","scope":"Captured filing text only. Attachment contents not examined."},"forum_topics":["attachments-only"],"primary_topic":"attachments-only","forum_title":"Attachment-only filing · Kevin Mottus, Outreach Director at CA Brain Tumor Assn."}